Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in 51Cr-release and CD107a assays

Journal of Immunological Methods

Volumn 406, Issue , 2014, Pages 1-9

  Mata, Mariana M ^a   Mahmood, Fareeha ^a   Sowell, Ryan T ^a   Baum, Linda L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ADCC; CD107a; Cryopreservation; Degranulation; NK cells; PBMC

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD56 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL SPECIFICITY; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CRYOPRESERVATION; DEGRANULATION; DEGRANULATION ASSAY; EFFECTOR CELL; FREEZE THAWING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADCC; CD107A; CRYOPRESERVATION; DEGRANULATION; NK CELLS; PBMC;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD14; ANTIGENS, CD56; B-LYMPHOCYTE SUBSETS; CELL DEGRANULATION; CELL LINE; CHROMIUM RADIOISOTOPES; CRYOPRESERVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; RECEPTORS, IGG;

EID: 84900851173     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.01.017     Document Type: Article

References (36)

1. Aktas E., Kucuksezer U.C., Bilgic S., Erten G., Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 2009, 254:149.
2. Alpert M.D., Harvey J.D., Lauer W.A., Reeves R.K., Piatak M., Carville A., Mansfield K.G., Lifson J.D., Li W., Desrosiers R.C., Johnson R.P., Evans D.T. ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog. 2012, 8:e1002890.
3. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004, 294:15.
4. Baum L.L., Cassutt K.J., Knigge K., Khattri R., Margolick J., Rinaldo C., Kleeberger C.A., Nishanian P., Henrard D.R., Phair J. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J. Immunol. 1996, 157:2168.
5. Boot J.H., Geerts M.E., Aarden L.A. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants. J. Immunol. 1989, 142:1217.
6. Borghaei H., Smith M.R., Campbell K.S. Immunotherapy of cancer. Eur. J. Pharmacol. 2009, 625:41.
7. Callery C.D., Golightly M., Sidell N., Golub S.H. Lymphocyte surface markers and cytotoxicity following cryopreservation. J. Immunol. Methods 1980, 35:213.
8. Chung A.W., Rollman E., Center R.J., Kent S.J., Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J. Immunol. 2009, 182:1202.
9. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146.
10. Costantini A., Mancini S., Giuliodoro S., Butini L., Regnery C.M., Silvestri G., Montroni M. Effects of cryopreservation on lymphocyte immunophenotype and function. J. Immunol. Methods 2003, 278:145.
11. + T-cells as target cells in natural killer cell cytotoxic assays. J. Vis. Exp. 2011, 49:e2668.
12. Disis M.L., dela Rosa C., Goodell V., Kuan L.Y., Chang J.C., Kuus-Reichel K., Clay T.M., Kim Lyerly H., Bhatia S., Ghanekar S.A., Maino V.C., Maecker H.T. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J. Immunol. Methods 2006, 308:13.
13. Gong J.H., Maki G., Klingemann H.G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994, 8:652.
14. Grzywacz B., Kataria N., Verneris M.R. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 2007, 21:356. (author reply 359).
15. Helguera G., Rodriguez J.A., Luria-Perez R., Henery S., Catterton P., Bregni C., George T.C., Martinez-Maza O., Penichet M.L. Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry. J. Immunol. Methods 2011, 368:54.
16. Hirsen D.J., Dubin B.A., Malham L.M. Repetitive testing and storage of human effector cells in natural killing and antibody-dependent cell-mediated cytotoxicity. Int. Arch. Allergy Appl. Immunol. 1983, 71:241.
17. Ichino Y., Ishikawa T. Effects of cryopreservation on human lymphocyte functions: comparison of programmed freezing method by a direct control system with a mechanical freezing method. J. Immunol. Methods 1985, 77:283.
18. Johansson S.E., Rollman E., Chung A.W., Center R.J., Hejdeman B., Stratov I., Hinkula J., Wahren B., Karre K., Kent S.J., Berg L. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol. 2011, 24:359.
19. Kantakamalakul W., Pattanapanyasat K., Jongrakthaitae S., Assawadarachai V., Ampol S., Sutthent R. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals. J. Immunol. Methods 2006, 315:1.
20. Kornbluth J., Spear B., Raab S.S., Wilson D.B. Evidence for the role of class I and class II HLA antigens in the lytic function of a cloned line of human natural killer cells. J. Immunol. 1985, 134:728.
21. Krzewski K., Gil-Krzewska A., Nguyen V., Peruzzi G., Coligan J.E. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood 2013, 121:4672.
22. Kute T., Stehle J.R., Ornelles D., Walker N., Delbono O., Vaughn J.P. Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells. Oncoimmunology 2012, 1:810.
23. Liu Q., Sun Y., Rihn S., Nolting A., Tsoukas P.N., Jost S., Cohen K., Walker B., Alter G. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J. Virol. 2009, 83:8705.
24. Manches O., Lui G., Chaperot L., Gressin R., Molens J.P., Jacob M.C., Sotto J.J., Leroux D., Bensa J.C., Plumas J. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood 2003, 101:949.
25. Mantegani P., Tambussi G., Galli L., Din C.T., Lazzarin A., Fortis C. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. Immunology 2009, 129:220.
26. Mata M.M., Iwema J.R., Dell S., Neems L., Jamieson B.D., Phair J., Cohen M.H., Anastos K., Baum L.L. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women. AIDS Res. Hum. Retrovir. 2014, 30:50.
27. Parsons M.S., Wren L., Isitman G., Navis M., Stratov I., Bernard N.F., Kent S.J. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J. Virol. 2012, 86:4488.
28. Pollara J., Hart L., Brewer F., Pickeral J., Packard B.Z., Hoxie J.A., Komoriya A., Ochsenbauer C., Kappes J.C., Roederer M., Huang Y., Weinhold K.J., Tomaras G.D., Haynes B.F., Montefiori D.C., Ferrari G. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 2011, 79:603.
29. Pross H.F., Maroun J.A. The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 1984, 68:235.
30. + T cells of HIV-1 infected individuals. J. Clin. Lab. Anal. 2008, 22:153.
31. Strong D.M., Ortaldo J.R., Pandolfi F., Maluish A., Herberman R.B. Cryopreservation of human mononuclear cells for quality control in clinical immunology. I. Correlations in recovery of K- and NK-cell functions, surface markers, and morphology. J. Clin. Immunol. 1982, 2:214.
32. Tollerud D.J., Brown L.M., Clark J.W., Neuland C.Y., Mann D.L., Pankiw-Trost L.K., Blattner W.A. Cryopreservation and long-term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis: effects on cell subset proportions and fluorescence intensity. J. Clin. Lab. Anal. 1991, 5:255.
33. Yamada T., Tomita T., Weiss L.M., Orlofsky A. Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells. Int. J. Parasitol. 2011, 41:595.
34. Yoshida R., Tazawa H., Hashimoto Y., Yano S., Onishi T., Sasaki T., Shirakawa Y., Kishimoto H., Uno F., Nishizaki M., Kagawa S., Fujiwara T. Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells. Cancer Immunol. Immunother. 2012, 61:1905.
35. Ziegner U.H., Frank I., Bernatowicz A., Starr S.E., Streckert H.J. Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1). Viral Immunol. 1992, 5:273.
36. Zolla-Pazner S. Identifying epitopes of HIV-1 that induce protective antibodies. Nat. Rev. Immunol. 2004, 4:199.